2011
DOI: 10.4172/2155-6156.1000146
|View full text |Cite
|
Sign up to set email alerts
|

Incretin-Based Therapies: What Do We Need To Know?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…The increasing prevalence of Type 2 diabetes is mainly due to reduced physical activity and consumption of unhealthy food and larger portion sizes in genetic susceptible individuals [16]. It is essential to note that the progressive nature of type 2 diabetes requires the combination of life style modification (diet and exercise) and antihyperglycemic agents in order to achieve adequate glycemic control [17].…”
Section: Type 2 Diabetesmentioning
confidence: 99%
“…The increasing prevalence of Type 2 diabetes is mainly due to reduced physical activity and consumption of unhealthy food and larger portion sizes in genetic susceptible individuals [16]. It is essential to note that the progressive nature of type 2 diabetes requires the combination of life style modification (diet and exercise) and antihyperglycemic agents in order to achieve adequate glycemic control [17].…”
Section: Type 2 Diabetesmentioning
confidence: 99%
“…The HNF4-α is a gene which codes for the transcription factor which regulates the gene transcription and expression in pancreatic beta cells. Which leads to Maturity-Onset Diabetes of the Young (MODY), an uncommon and autosomal dominant, non-insulin dependent form of diabetes [84]. This provides us information for a start for further study to make the easier way of Prognosis, Diagnosis and treatment.…”
Section: Molecular and Signaling Biomarkersmentioning
confidence: 99%